OLI recorded this information on 6/19/2015
|Share Amount Authorized:
||In addition to increasing the dividend, the board today approved the authorization of an additional 80 million ordinary shares, which represents approximately 6 percent of the company's total basic shares outstanding, to be purchased under Medtronic's Share Repurchase Plan. There is no specific time period associated with the plan. Over the past 5 years, Medtronic has repurchased $8.3 billion of its outstanding shares, or 176 million shares, which contributed approximately 10 percent to the reduction in the company's outstanding shares prior to the acquisition of Covidien last quarter.
Medtronic is a medical technology, services and solutions company. Co.'s operating segments are: Cardiac and Vascular, which is made up of the cardiac rhythm and heart failure, coronary and structural heart, and aortic, peripheral and venous divisions; Minimally Invasive Therapies, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Restorative Therapies, which is made up of the spine, brain therapies, specialty therapies, and pain therapies divisions; and Diabetes, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
Medtronic SEC Filing Email Alerts Service
Open the MDT Page at The Online Investor »
Open the MDT Page at The Online Investor (in a new window) »